SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 331 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $507,095 | -71.4% | 4,428 | -65.6% | 0.08% | -69.3% |
| Q1 2023 | $1,771,942 | -25.9% | 12,856 | -30.4% | 0.24% | -27.8% |
| Q4 2022 | $2,392,306 | +82.6% | 18,462 | +55.7% | 0.34% | +79.8% |
| Q3 2022 | $1,310,000 | +421.9% | 11,854 | +269.4% | 0.19% | +337.2% |
| Q1 2022 | $251,000 | -81.9% | 3,209 | -82.8% | 0.04% | -76.6% |
| Q1 2021 | $1,388,000 | +232.9% | 18,621 | +526.5% | 0.18% | +247.2% |
| Q3 2020 | $417,000 | – | 2,972 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |